NORTHERN TRUST CORP - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,691,603
-7.5%
211,715
+0.7%
0.00%
Q2 2023$1,829,645
+200.7%
210,304
+1.6%
0.00%
Q1 2023$608,383
-14.7%
206,933
+1.5%
0.00%
Q4 2022$713,314
-56.9%
203,804
-2.7%
0.00%
Q3 2022$1,656,000
-1.7%
209,415
-2.2%
0.00%
Q2 2022$1,685,000
-33.6%
214,049
+2.5%
0.00%
Q1 2022$2,538,000
+11.5%
208,845
+12.3%
0.00%
Q4 2021$2,277,000
+13.3%
186,027
-3.5%
0.00%
Q3 2021$2,009,000
+220.4%
192,828
+176.3%
0.00%
Q2 2021$627,000
+35.4%
69,783
+53.3%
0.00%
Q1 2021$463,000
+372.4%
45,521
+205.0%
0.00%
Q4 2020$98,00014,9250.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
WOODSTOCK CORP 22,253$514,2670.06%
MASSMUTUAL TRUST CO FSB/ADV 108$2,4960.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders